0001690870-17-000001.txt : 20170130 0001690870-17-000001.hdr.sgml : 20170130 20170130163159 ACCESSION NUMBER: 0001690870-17-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170130 DATE AS OF CHANGE: 20170130 EFFECTIVENESS DATE: 20170130 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Impact Genomics, Inc. CENTRAL INDEX KEY: 0001690870 IRS NUMBER: 473000529 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-275823 FILM NUMBER: 17557860 BUSINESS ADDRESS: STREET 1: 2645 RIDGEGATE ROAD CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: 215-519-6638 MAIL ADDRESS: STREET 1: 2645 RIDGEGATE ROAD CITY: LA JOLLA STATE: CA ZIP: 92037 D/A 1 primary_doc.xml X0707 D/A LIVE 0001690870 Impact Genomics, Inc. 2645 RIDGEGATE ROAD LA JOLLA CA CALIFORNIA 92037 215-519-6638 DELAWARE None None Corporation true 2014 Kenneth Nesmith c/o Impact Genomics, Inc. 2645 Ridgegate Row La Jolla CA CALIFORNIA 92037 Executive Officer Director Samuel Levy c/o Impact Genomics, Inc. 2645 Ridgegate Row La Jolla CA CALIFORNIA 92037 Executive Officer Director John Spinosa c/o Impact Genomics, Inc. 2645 Ridgegate Row La Jolla CA CALIFORNIA 92037 Executive Officer Director Other Decline to Disclose 06b true 0001690870-16-000002 2016-11-23 false true false 0 10224999 10215947 9052 $224,996.79 cancellation of indebtedness, that is designated Series A-1 stock; $9,990,948.13 new-cash, that is designated Series A stock false 32 0 0 0 false Impact Genomics, Inc. /s/ Kenneth Nesmith Kenneth Nesmith Chief Executive Officer 2017-01-30